Coherus Oncology, Inc. CHRS
0.37 USD -0.02 (-4.47%)
Regular-session close
0.37 0.00 +0.59%
After hours · Nov 20, 6:09 PM ET
0.3628 Day range 0.4084
0.3628 52-week range 2.62
- YTD
- -73.96%
- 1 year
- -66.38%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 42.17M | 26.39M | 257.24M | 211.04M | 326.55M | |
| 28.36M | 17.66M | 98.25M | 140.96M | 268.96M | |
| -181.13M | -199.65M | -203.20M | -256.88M | -263.86M | |
| 168.02M | 28.51M | -237.89M | -291.75M | -287.10M | |
| 1.43 | 0.25 | -2.53 | -3.76 | -3.81 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 88.88M | 125.99M | 102.89M | 63.55M | 417.19M | |
| 258.34M | 448.53M | 629.60M | 480.85M | 679.33M | |
| 197.33M | 580.52M | 823.03M | 618.26M | 581.61M | |
| 37.05M | 268.21M | 478.70M | 476.10M | 415.53M | |
| 61.01M | -131.99M | -193.43M | -137.42M | 97.73M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -138.51M | -20.44M | -174.88M | -241.12M | -37.43M | |
| 375.09M | 230.32M | 144.64M | -166.85M | -138.41M | |
| -273.70M | -186.97M | 69.60M | 54.33M | 51.88M | |
| -37.13M | 22.91M | 39.36M | -353.65M | -123.96M |
